Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Datta Meghe Institute of Higher Education and Research (DMIHER)
Eligibility
Inclusion criteria
Inclusion criteria: 1. All female patients undergoing mastectomy for breast cancer during the study period were included. 2. All female patients diagnosed with breast carcinoma on histopathological examination. 3. All females with breast carcinoma with no history of previous treatment for the same
Exclusion criteria
Exclusion criteria: 1. All the patients whose treatment had already started before the pre treatment NLR was determined. 2. All male breast cancer patients were excluded from the study. 3. All patients diagnosed with lesions other than carcinoma like benign breast lesions, mesenchymal tumors were excluded. 4. All patients who have undergone incisional biopsy, trucut biopsy and diagnosed with breast carcinoma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study investigates the signifance of Neutrophil- Lymphocyte ratio as a predictive tumour behaviour marker in correlation to established histopathological and immunohistochemistry parameters.Timepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Prita Hejib
Datta Meghe Institute of Higher Education and Research
Outcome results
None listed